[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

March 2024 | 150 pages | ID: P211C47A494CEN
Lucintel

US$ 4,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Get it in 2 to 4 weeks by ordering today

Particle Therapy Trends and Forecast

The future of the global particle therapy market looks promising with opportunities in the treatment and research markets. The global particle therapy market is expected to reach an estimated $1.2 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are escalating incidence of cancer, surging embrace of particle therapy in clinical research, and rising count of particle therapy facilities globally.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Particle Therapy by Segment

The study includes a forecast for the global particle therapy by type, cancer type, system, application, and region.

Particle Therapy Market by Type [Shipment Analysis by Value from 2018 to 2030]:
  • Proton Therapy
  • Heavy-Ion Therapy
Particle Therapy Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
  • Pediatric Cancer
  • Lung Cancer
  • Breast Cancer
  • Head Cancer
  • Others
Particle Therapy Market by System [Shipment Analysis by Value from 2018 to 2030]:
  • Multi-Room Systems
  • Single-Room Systems
Particle Therapy Market by Application [Shipment Analysis by Value from 2018 to 2030]:
  • Treatment
  • Research
  • Others
Particle Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:
  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World
List of Particle Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies particle therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the particle therapy companies profiled in this report include-
  • IBA Worldwide
  • Varian Medical Systems
  • Hitachi
  • Mevion Medical Systems
  • Sumitomo Heavy Industries
  • Provision Healthcare
  • Toshiba Medical Systems
  • Optivus Proton Therapy
  • Protom International
  • Advanced Oncotherapy
Particle Therapy Market Insights

Lucintel forecasts that proton is expected to witness the highest growth over the forecast period.

Within this market, treatment is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Particle Therapy Market

Market Size Estimates: Particle therapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Particle therapy market size by various segments, such as by type, cancer type, system, application, and region in terms of value ($B).

Regional Analysis: Particle therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, cancer types, systems, applications, and regions for the particle therapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the particle therapy market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the particle therapy market size?

Answer: The global particle therapy market is expected to reach an estimated $1.2 billion by 2030.

Q2. What is the growth forecast for particle therapy market?

Answer: The global particle therapy market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the particle therapy market?

Answer: The major drivers for this market are escalating incidence of cancer, surging embrace of particle therapy in clinical research, and rising count of particle therapy facilities globally.

Q4. What are the major segments for particle therapy market?

Answer: The future of the particle therapy market looks promising with opportunities in the treatment and research markets.

Q5. Who are the key particle therapy market companies?

Answer: Some of the key particle therapy companies are as follows:
  • IBA Worldwide
  • Varian Medical Systems
  • Hitachi
  • Mevion Medical Systems
  • Sumitomo Heavy Industries
  • Provision Healthcare
  • Toshiba Medical Systems
  • Optivus Proton Therapy
  • Protom International
  • Advanced Oncotherapy
Q6. Which particle therapy market segment will be the largest in future?

Answer: Lucintel forecasts that proton is expected to witness the highest growth over the forecast period.

Q7. In particle therapy market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the particle therapy market by type (proton therapy and heavy-ion therapy), cancer type (pediatric cancer, lung cancer, breast cancer, head cancer, and others), system (multi-room systems and single-room systems), application (treatment, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Particle Therapy Market, Particle Therapy Market Size, Particle Therapy Market Growth, Particle Therapy Market Analysis, Particle Therapy Market Report, Particle Therapy Market Share, Particle Therapy Market Trends, Particle Therapy Market Forecast, Particle Therapy Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY

2. GLOBAL PARTICLE THERAPY MARKET : MARKET DYNAMICS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Particle Therapy Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Particle Therapy Market by Type
  3.3.1: Proton Therapy
  3.3.2: Heavy-Ion Therapy
3.4: Global Particle Therapy Market by Cancer Type
  3.4.1: Pediatric Cancer
  3.4.2: Lung Cancer
  3.4.3: Breast Cancer
  3.4.4: Head Cancer
  3.4.5: Others
3.5: Global Particle Therapy Market by System
  3.5.1: Multi-Room Systems
  3.5.2: Single-Room Systems
3.6: Global Particle Therapy Market by Application
  3.6.1: Treatment
  3.6.2: Research
  3.6.3: Others

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030

4.1: Global Particle Therapy Market by Region
4.2: North American Particle Therapy Market
  4.2.1: North American Particle Therapy Market by Type: Proton Therapy and Heavy-Ion Therapy
  4.2.2: North American Particle Therapy Market by Application: Treatment, Research, and Others
4.3: European Particle Therapy Market
  4.3.1: European Particle Therapy Market by Type: Proton Therapy and Heavy-Ion Therapy
  4.3.2: European Particle Therapy Market by Application: Treatment, Research, and Others
4.4: APAC Particle Therapy Market
  4.4.1: APAC Particle Therapy Market by Type: Proton Therapy and Heavy-Ion Therapy
  4.4.2: APAC Particle Therapy Market by Application: Treatment, Research, and Others
4.5: ROW Particle Therapy Market
  4.5.1: ROW Particle Therapy Market by Type: Proton Therapy and Heavy-Ion Therapy
  4.5.2: ROW Particle Therapy Market by Application: Treatment, Research, and Others

5. COMPETITOR ANALYSIS

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

6.1: Growth Opportunity Analysis
  6.1.1: Growth Opportunities for the Global Particle Therapy Market by Type
  6.1.2: Growth Opportunities for the Global Particle Therapy Market by Cancer Type
  6.1.3: Growth Opportunities for the Global Particle Therapy Market by System
  6.1.4: Growth Opportunities for the Global Particle Therapy Market by Application
  6.1.5: Growth Opportunities for the Global Particle Therapy Market by Region
6.2: Emerging Trends in the Global Particle Therapy Market
6.3: Strategic Analysis
  6.3.1: New Product Development
  6.3.2: Capacity Expansion of the Global Particle Therapy Market
  6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Particle Therapy Market
  6.3.4: Certification and Licensing

7. COMPANY PROFILES OF LEADING PLAYERS

7.1: IBA Worldwide
7.2: Varian Medical Systems
7.3: Hitachi
7.4: Mevion Medical Systems
7.5: Sumitomo Heavy Industries
7.6: Provision Healthcare
7.7: Toshiba Medical Systems
7.8: Optivus Proton Therapy
7.9: Protom International
7.10: Advanced Oncotherapy


More Publications